Objective: Some studies suggest that hospitalizations for certain conditions, called ambulatory care sensitive conditions (ACSCs), are potentially avoidable. However, almost no study has addressed the risk of ACSC hospitalizations specifically for patients with severe mental illness. Our study examines the risk of ACSC hospitalizations among patients with schizophrenia in Taiwan, using a 5-year, nationwide, population-based database.
M any hospitalizations may be considered unavoidable, because the situation requiring hospitalization developed acutely and was unanticipated. However, some studies suggest that hospitalizations for certain conditions, called ACSCs, are potentially avoidable. [1] [2] [3] ACSC hospitalizations are defined as admissions for indications that could have been prevented by prompt and appropriate outpatient health care services. In 1992, a study by Weissman et al 4 identified 12 avoidable hospital conditions, which have become an established tool for assessing primary care access and effectiveness, especially for vulnerable population groups. [5] [6] [7] A growing number of studies have found that vulnerable groups, such as minorities, the elderly, the geographically isolated, and people with low socioeconomic status or without insurance, have relatively high rates of avoidable hospitalization. [8] [9] [10] [11] [12] [13] [14] However, almost no study has addressed the risk of ACSC hospitalizations specifically for patients with severe mental illness, such as schizophrenia. Schizophrenia is the most chronic and disabling of all major mental disorders and uncomfortable symptoms, such as hallucinations, delusions, disorganized speech and thinking, poor planning, reduced motivation, and blunted responses, may cause patients to be deficient in health awareness and less likely to follow prescribed treatment. [15] [16] [17] [18] [19] As far as we know, only one study, by Li et al, 20 reported that patients with schizophrenia experience a higher risk of hospitalization owing to ACSCs (AOR 1.83; 95% CI 1.50 to 2.24) than the general population. And during ACSCs hospitalization, patients with schizophrenia showed significantly higher hospital cost and longer length of stay than patients without coexisting mental illnesses. However, their study sample was only limited to adults aged 20 to 64 years in New York State, and data from other populations is still lacking. As historical and sociocultural circumstances faced by patients with schizophrenia are substantially different, barriers to access health care may vary in various cultures or countries. In addition, it is noteworthy to investigate whether the risk of ACSC hospitalization in vulnerable groups persisted in a national health insurance system that provides universal health care to citizens.
Our study therefore aimed to examine the risk of ACSC hospitalizations among patients with schizophrenia in Taiwan, using a 5-year, nationwide, population-based database. Taiwan initiated its NHI program in 1995 to provide affordable health care to all citizens. The data now available from Taiwan allows us to trace all use of medical services for all enrollees, presenting a unique opportunity to clarify the risk of avoidable hospitalizations among patients with schizophrenia.
Methods

Database
Our study used the LHID released by the Taiwan National Health Research Institutes and provided to scientists in Taiwan for research purposes. As of 2007, 22.60 million of Taiwan's 22.96 million population were enrolled in the NHI program. The LHID contains all of the original claims data for 1 million beneficiaries, randomly sampled from the 2005 Registry of Beneficiaries of the NHI program. The Taiwan National Health Research Institutes reports that there is no significant difference in the sex distribution, age distribution, or average payroll-related insurance premium between the patients in the LHID and the original claims data of all enrollees. The LHID thus offers an excellent opportunity to examine the risk of ACSC hospitalizations among patients with schizophrenia.
As the LHID consists of de-identified secondary data released to the public for research purposes, our study was exempt from full review by the Institutional Review Board of the Taipei Medical University.
Study Sample
We identified all patients who were hospitalized or visited ambulatory care centres with a principal diagnosis of schizophrenia (any ICD-9-CM 295.XX code other than 295.7 schizoaffective disorder) between January and December 2001 (n = 3131). As administrative data are often criticized for diagnostic validity, we included only patients who had at least 3 consistent schizophrenia diagnoses in their ambulatory care visits or one principal diagnosis of schizophrenia requiring hospitalization in 2001 as study group (n = 2550). In addition, we excluded patients aged 17 years and younger (n = 41) or aged 81 years and older (n = 6). Ultimately, our study group included 2503 patients with schizophrenia.
We also extracted the comparison group from the LHID. After excluding patients who had been diagnosed with schizophrenia during the period between 1996 and 2006, we randomly selected 20 024 enrollees (8 for every schizophrenia patient) from the 2001 Registry for Beneficiaries of LHID, corresponding with the study group in terms of sex and age (18 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 to 80 years). A total of 22 527 sampled patients were included in our study.
Variables of Interest
The key dependent variable was the number of ACSC hospitalizations during the period between 2002 and 2006. In our study, we adopted the following 12 conditions proposed by Weissman et al 4 as ACSC hospitalizations: ruptured appendix, asthma, cellulitis, congestive heart failure, diabetes, gangrene, hypokalemia, immunizable conditions, malignant hypertension, pneumonia, pyelonephritis, and perforated or bleeding ulcer. The key independent variable was whether a patient had a diagnosis of schizophrenia in 2001.
In our study, we also adjusted for sociodemographic characteristics in the regression modelling. The sociodemographic characteristics consisted of a patient's sex, age, level of urbanization, geographic location (northern, central, eastern, and southern Taiwan) of residence within a community, and monthly income (0, NT$1 to NT$15 840, NT$15 841 to NT$25 000, and NT$25 001 or greater). Urbanization levels are divided into 5 strata in Taiwan, with level 1 referring to the most urbanized and level 5 referring to the least urbanized communities. We selected NT$15 840 as the first income level cut-off point as this is the government-mandated minimum wage for full-time employees in Taiwan.
Statistical Analysis
We used the SAS statistical package, Version 8.2 (SAS Institute Inc, Cary NC) to perform all analyses in our study. Pearson chi-square tests were conducted to examine the differences between the patients with and without schizophrenia in terms of sociodemographic characteristics. Poisson regression analysis was then performed, in which the number of ACSC hospitalizations during the period between 2002 and 2006 was regressed against the independent variable of whether a patient had a schizophrenia diagnosis in 2001. A significance level of 0.05 was selected to determine the significance of predictors in the models. Table 1 describes the distribution of demographic characteristics for patients with and without schizophrenia. Among the 22 527 sampled patients, the mean age was 38.5 years (SD 12.9 years), and about 56.6% were female. The chi-square tests show that there were significant differences in monthly income (P < 0.001) and geographic region (P < 0.001) between these 2 groups. Patients with schizophrenia were more likely to have lower monthly incomes and to reside in the central and eastern parts of Taiwan, compared with the comparison cohort. However, it should be noted that the differences in region were very small in magnitude and might merely come from the large sample size.
Results
The rate of ACSC hospitalizations for the 2 groups is provided in Table 2 . Overall, the mean number of ACSC hospitalizations during the 5-year period for the sampled patients was 0.13 (SD 0.96). For patients with schizophrenia the mean number was 0.34 (SD 2.21) and 0.10 (0.68) for patients without schizophrenia (P < 0.001). In addition, 9.83% of patients with schizophrenia and 4.71% of patients in the comparison group experienced ACSC hospitalizations between 2002 and 2006 (P < 0.001). The chi-square tests illustrated that patients with schizophrenia had significantly higher rates of ACSC hospitalizations for asthma (P = 0.04), cellulitis (P < 0.001), diabetes (P < 0.001), hypokalemia (P < 0.001), and pneumonia (P < 0.001) than patients in the comparison group. Table 3 presents the results of the Poisson regression analysis, revealing that after adjusting for a patient's sex, age, level of urbanization, geographic location of residence within a community, and monthly income, patients with schizophrenia had a 3.26-fold higher (95% CI 3.00 to 3.54, P < 0.001) risk of ACSC hospitalization than the comparison participants. The risk of ACSC hospitalizations rose with increasing patient age.
We further analyzed the risk of ACSC hospitalization, excluding the conditions of diabetes, hypertension, and asthma among patients with schizophrenia. We excluded these 3 conditions from the analysis because hospitalizations for these 3 conditions only occurred among patients who had these disorders. Prior studies have consistently shown that patients with schizophrenia are more likely to have diabetes, hypertension, and asthma than the general population, and this would increase the risk of ACSC hospitalizations for these 3 conditions. 21, 22 Similarly, we found that after excluding these 3 conditions, patients with schizophrenia had a 2.46-fold higher risk of ACSC hospitalization (95% CI 2.12 to 2.86, P < 0.001) compared with patients in the comparison group, after adjusting for other potential confounders (Table 4 ).
Discussion
The health disadvantages experienced by patients with schizophrenia have been recognized. Patients with schizophrenia are more likely to require health care but are less likely to receive health care services. 19, [23] [24] [25] [26] Recent studies suggest that even when these people gain access to the health care system, they are less likely than other patients to receive high-quality treatment. 25, [27] [28] [29] In a population-based record-linkage analysis of data from 1995 to 2001 in Canada, Kisely et al 30 also found that psychiatric patients experienced higher mortality risks and were significantly less likely to access some procedures for circulatory disease, even in a universal health care system that is free at delivery. Despite well-documented research detailing a lack of appropriate medical care among patients with schizophrenia, there is a paucity of knowledge about how to measure quality of care for this population.
It has been noted that the rate of ACSC hospitalizations can serve as an indicator of potentially unmet needs for health services and provides a basis for assessing quality. 31 However, to date, only one study, by Li et al, 20 has explored the association between schizophrenia and ACSC admissions. Using New York State hospital discharge data for 2004, Li et al 20 compared the ACSC admission patterns for medical patients with and without coexisting mental disorders. They found that patients with schizophrenia were significantly associated with a 1.83 times increased odds of ACSC admissions. As far as we know, our study is the first nationwide, population-based study to systematically examine hospitalizations owing to ACSC to see whether there was a difference between patients with or without schizophrenia. The implementation of NHI in Taiwan has successfully reduced financial barriers to accessing care for all, including people with mental illness. However, we found that after adjusting for potential confounders, patients with schizophrenia were still 2.46 times more likely than the comparison participants to experience ACSC hospitalizations. It clearly demonstrates that even under the NHI program, patients with schizophrenia continue to have reduced access to physical health care, and the quality of care they receive is lower than that of the general population.
There are many potential mechanisms by which schizophrenia might impede patients from communicating effectively with caregivers. For example, typical consequences of schizophrenia, such as cognitive impairment, social isolation, suspicion, and possible pain insensitivity may cause schizophrenic patients to be less likely to seek medical help, to promptly report physical symptoms, or to follow prescribed treatment. [15] [16] [17] [18] In addition, owing to their impaired capacity to recognize or articulate the signs of emerging medical illness, these patients often face delays in diagnosis and treatment for somatic comorbidities. [32] [33] [34] Further, some primary care providers may be unskilled or feel uncomfortable dealing with this population, and some psychotic symptoms, such as somatic delusions, may lead physicians who are less experienced in treating patients with schizophrenia to misdiagnose or delay diagnosis in certain cases. 29 Conversely, some psychiatrists are unable or unwilling to perform physical examinations, or are not up to date on the management of even common physical diseases. Consequently, all of these factors related to the disease, the patient, and the physician may explain the reduced access and quality of physical health care among people with schizophrenia. 25 Findings in our study have both clinical practice and policy implications. The incremental resource use related to ACSC hospitalizations for patients with schizophrenia indicates that adequate distribution of medical resources and establishment of proper health care policies are crucial to effectively managing this illness. Several studies suggest that integrated mental and medical care models could be a cost-efficient way to improve access to ambulatory care for patients. 35, 36 Further, some studies have suggested mental health care professionals should perform at least a standard routine assessment of their patients, to identify signs of physical health problems. 25 Moreover, primary care providers must overcome their reluctance to treat people with severe mental illness. In addition, they should be encouraged to familiarize themselves with the most common reasons for underdiagnosis or misdiagnosis of physical illness in patients with schizophrenia and learn effective ways to interact and communicate with this population. Currently, physicians have no guidelines on how to manage somatic morbidity in patients with chronic psychosis. The development and implementation of a set of guidelines could improve the quality of care for patients with schizophrenia, if these guidelines addressed the deficiencies in physicians for these patients. Numerous studies have found the risks for ACSC hospitalizations is strongly associated with race 37,38 and insurance status. 4, 11, 39, 40 As over 98% of Taiwan residents are of Han Chinese ethnicity and more than 96% of the population has enrolled in the NHI, our study samples are drawn from a population in which barriers to health care owing to race and insurance are reduced, thus avoiding possible confounding effects of this sort. In addition to the advantages mentioned above, our study has other strengths. First, because it used nationwide populationbased datasets, its robust findings can be generalized to the population as a whole. Second, the large sample size provides ample statistical power to detect differences between schizophrenia and nonschizophrenia groups, after adjusting for confounding variables.
Four inherent limitations of administrative datasets merit note. First, because we identified patients diagnosed with schizophrenia from administrative claims data by ICD-9-CM code, the validity of diagnoses could be compromised.
To ensure the validity of the schizophrenia diagnoses, our study sample included only patients who had at least 3 consistent schizophrenia diagnoses in their ambulatory care visits or one principal diagnosis of schizophrenia during hospitalization during the study period. Second, because patients with schizophrenia may be misidentified as nonschizophrenia patients if they do not seek appropriate medical care, misclassification would likely bias our results toward the null. Third, medical comorbidities might not be adjusted appropriately in our study. Instead, we attempted to perform analysis excluding the conditions of diabetes, hypertension, and asthma as patients with schizophrenia were more likely to have these conditions and might consequently increase the risk of ACSC hospitalizations. 21, 22 Finally, because we used a claims database, our study was unable to examine the effects of potential confounders, such as the highest educational level, marital status, social support, local health infrastructure, and family cohesion, in the regression model, which could compromise our findings.
Because the extent of ACSC admissions affected by schizophrenia has not been clearly established, our report uses a comprehensive dataset in Taiwan that provides a unique opportunity to evaluate the quality of care received by patients suffering from schizophrenia. In summary, we found that patients with schizophrenia were at a higher risk for hospitalization owing to ACSCs, despite the NHI system providing universal coverage to citizens. It demonstrated that the quality of physical health care received by these patients is indeed poorer than that of the general population, and the burden of disease and potentially preventable morbidity is disproportionately falling on this vulnerable group. This phenomenon may signal failures in public health and medical care, and points to social factors and personal behaviour. Therefore, how to offer easily accessible health care for patients with schizophrenia is an important challenge for policy-makers. Future studies examining these issues from multiple perspectives are warranted, including sociological factors, such as social support, local health infrastructure, and family cohesion, to enable a more specific interpretation of these findings.
Résumé : Le risque accru d'hospitalisations évitables chez les patients souffrant de schizophrénie
Objectif : Des études suggèrent que les hospitalisations pour certains troubles, appelés troubles pour lesquels le suivi ambulatoire serait à privilégier (TSAP), peuvent être évitées. Cependant, aucune étude n'a abordé le risque d'hospitalisations pour TSAP spécifiquement pour les patients souffrant de grave maladie mentale. Notre étude examine le risque d'hospitalisations pour TSAP chez les patients souffrant de schizophrénie à Taïwan, à l'aide d'une base de données nationale dans la population sur 5 ans. 
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